These findings strongly suggest that neuroblastoma cell sensitivity to GSK2830371 is primarily dependent on p53 activity, and that effects on additional WIP1 substrates that lie upstream of p53 will contribute to growth inhibition only in the context of a functional P53 pathway. Here, PPM1D is linked to neuroblastoma.